Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Cryptos Muted Ahead Of Central Bank Decisions
-
Goldman Sachs Rises As Q2 Results Beat The Street
-
Mark Yusko Predicts Bitcoin's Surge Due to Potential $300 Billion Institutional Investment
-
Immunome Surges On News Of Merger With Morphimmune
-
Heritage Insurance Drops 10% After Projecting Catastrophe Losses